ADA Standards of Care 2025 support CGM across a broader clinical spectrum, while Medicare criteria now cover all insulin-treated patients and certain non-insulin patients with documented problematic hypoglycemia
patients should use backup or non-oral contraception for 4 weeks after each dose change
For those looking to enhance the regenerative results from peptide therapy without surgery, we may recommend EZGel PRF in NYC
coli, plus 13C and 15N isotope labeling
A 2025 systematic review (PMC, 36 studies, 1993-2024) found consistent improvement in tendon, ligament, muscle, and bone healing in animal models
Biomarker Assessment Before & During MIC B12 Therapy Baseline serum B12 and methylmalonic acid (MMA) levels provide objective context for whether MIC B12 therapy is appropriate